Efficacy and Safety of Vatelizumab in Patients Who Completed Treatment in Study DRI13839

Clinical trial NCT02306811 · TERMINATED

Trial details

NCT number: NCT02306811
Sponsor: Genzyme, a Sanofi Company
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Relapsing-remitting Multiple Sclerosis

Start date: 2015-02-01
Primary completion: 2016-04-01
Enrollment: 62

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.